Medical treatment of prolactinomas

被引:88
作者
Molitch, ME [1 ]
机构
[1] Northwestern Univ, Sch Med, Ctr Endocrinol Metab & Mol Med, Chicago, IL 60611 USA
关键词
D O I
10.1016/S0889-8529(05)70061-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prolactinomas are a common cause of reproductive and sexual dysfunction, Once other causes of hyperprolactinemia have been excluded with a careful history physical examination, routine chemistries, and a TSH, MR imaging or computerized tomography will delineate the size and extent of the tumor. Medical therapy is the initial treatment of choice. When infertility is the primary indication for treatment, bromocriptine use has an extensive safety experience and is preferred. For other indications, however, cabergoline appears to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective.
引用
收藏
页码:143 / +
页数:28
相关论文
共 171 条
[1]   DISCORDANT RESPONSES OF PROLACTINOMA TO 2 DIFFERENT DOPAMINE AGONISTS [J].
AHMED, SR ;
SHALET, SM .
CLINICAL ENDOCRINOLOGY, 1986, 24 (04) :421-426
[2]   PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY OF CABERGOLINE, A PROLACTIN-LOWERING DRUG, AFTER ADMINISTRATION OF INCREASING ORAL DOSES (0.5, 1.0, AND 1.5 MILLIGRAMS) IN HEALTHY MALE-VOLUNTEERS [J].
ANDREOTTI, AC ;
PIANEZZOLA, E ;
PERSIANI, S ;
PACCIARINI, MA ;
BENEDETTI, MS ;
PONTIROLI, AE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03) :841-845
[3]  
ANNIKO M, 1981, ACTA PATH MICRO IM A, V89, P41
[4]   DYNAMICS OF PROLACTIN SECRETION IN PATIENTS WITH HYPOPITUITARISM AND PITUITARY MACROADENOMAS [J].
ARAFAH, BM ;
NEKL, KE ;
GOLD, RS ;
SELMAN, WR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (12) :3507-3512
[5]   VASOACTIVE INTESTINAL POLYPEPTIDE IS SYNTHESIZED IN ANTERIOR-PITUITARY TISSUE [J].
ARNAOUT, MA ;
GARTHWAITE, TL ;
MARTINSON, DR ;
HAGEN, TC .
ENDOCRINOLOGY, 1986, 119 (05) :2052-2057
[6]   Abnormal transduction mechanisms in pituitary adenomas [J].
Barlier, A ;
PellegriniBouiller, I ;
Caccavelli, L ;
Gunz, G ;
MorangeRamos, I ;
Jaquet, P ;
Enjalbert, A .
HORMONE RESEARCH, 1997, 47 (4-6) :227-234
[7]   CLINICAL AND PATHOLOGICAL EFFECTS OF BROMOCRIPTINE ON PROLACTIN-SECRETING AND OTHER PITUITARY-TUMORS [J].
BARROW, DL ;
TINDALL, GT ;
KOVACS, K ;
THORNER, MO ;
HORVATH, E ;
HOFFMAN, JC .
JOURNAL OF NEUROSURGERY, 1984, 60 (01) :1-7
[8]  
BEREZIN M, 1991, ISRAEL J MED SCI, V27, P375
[9]   DOPAMINE AGONISTS AND PITUITARY-TUMOR SHRINKAGE [J].
BEVAN, JS ;
WEBSTER, J ;
BURKE, CW ;
SCANLON, MF .
ENDOCRINE REVIEWS, 1992, 13 (02) :220-240
[10]   MISINTERPRETATION OF PROLACTIN LEVELS LEADING TO MANAGEMENT ERRORS IN PATIENTS WITH SELLAR ENLARGEMENT [J].
BEVAN, JS ;
BURKE, CW ;
ESIRI, MM ;
ADAMS, CBT .
AMERICAN JOURNAL OF MEDICINE, 1987, 82 (01) :29-32